GLIMEPIRIDE 2mg. IP + METFORMIN 500mg. IP + VOGLIBOSE 0.3mg. IP

A triple combination of glimepiride, metformin, and voglibose that treats high blood sugar in type 2 diabetes. A highly effective and safe triad in controlling all the glycemic parameters like HbA1c, FPG, and PPHG for optimal management of type 2 diabetes. (A. A. FARUQUI, 2015) A good therapeutic option for the management of uncontrolled glycemia who is having poor glycemic control. (A. A. FARUQUI, 2015) An effective drug in reducing the risk of weight gain in patients with type 2 diabetes and alleviates the risk of developing co-morbidities associated with weight gain such as obesity and dyslipidemia. (A. A. FARUQUI, 2015) A promising treatment option for the clinical management of Type 2 diabetes. (A. A. FARUQUI, 2015) Potentially ameliorates glycemic control and reduces further microvascular and cardiovascular complications. (Ashok K. Das, 2022) Improves insulin sensitivity and reduces postprandial blood glucose by regulating glucose absorption. (Mathew John, 2015)